As we previously mentioned, the routine genetic screening for at least five recurrent BRCA1 mutations (c.5266dup, c.181T>G, c.3700_3704del, c.68_69delAG, and c.4034delA) in all ovarian cancer patients in the Polish population should be performed 30. This evidence concerns the gene BRCA1 and ovarian carcinoma.